Protective effects of PPARγ agonist in glomerulosclerosis rats induced by adriamycin

Renal Failure

Volumn 34, Issue 7, 2012, Pages 940-941

  Zhou, Tian Biao ^a   Ou, Chao ^a   Luo, Cheng Piao ^a   Xu, Hui Ling ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 4; DOXORUBICIN; FIBRONECTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROTEIN; ROSIGLITAZONE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; DOWN REGULATION; GLOMERULOSCLEROSIS; IMMUNOHISTOCHEMISTRY; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; URINARY EXCRETION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HYPOGLYCEMIC AGENTS; PPAR GAMMA; RATS; THIAZOLIDINEDIONES;

EID: 84863876749     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.691066     Document Type: Letter

References (2)

1. Zuo Y, Yang HC, Potthoff SA, et al. Protective effects of PPARγ agonist in acute nephrotic syndrome. Nephrol Dial Transplant. 2012;27:174-181.
2. Zhou TB, Qin YH, Lei FY, Su LN, Zhao YJ, Huang WF. All-trans retinoic acid regulates the expression of apolipoprotein E in rats with glomerulosclerosis induced by Adriamycin. Exp Mol Pathol. 2011;90:287-294.